E-Mail
DURHAM, N.C. - A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease.
Researchers at Duke Cancer Institute enrolled 50 Black and 50 white men with advanced prostate cancer to test whether there were outcome differences on treatment with the hormone therapy abiraterone acetate plus the steroid prednisone. In retrospective data reviews, the Duke researchers had previously found racial differences in PSA responses among advanced prostate cancer patients.
songs. we re back on a tuesday morning, december 7, 2010. we re going to hear from natasha in a little while. take a look outside, it s a cold morning out on rockefeller plaza. it s in the 30s, a little windchill in the 20s. we got a nice group of people hanging out, we appreciate that as well. coming up in this half hour, elizabeth edwards battle with cancer, she has decided to stop seeking treatment for her breast cancer on the advice of her doctors. coming up, the latest on her condition and her emotional message to her friends and supporters. and then changing gears in our diet s.o.s. joy some delicious food choices if you re trying to cut back on salt. and we show you some great gifts at discounted prices, some as much as 90%, 91% off just for today viewers. this is the best ever that i have seen. we have got a deal for everyone on your list, whether they re a steak lover or a jewelry lover. stay by your computer for this one. a lot to get to, but first ann is on